JP2000507952A5 - - Google Patents

Download PDF

Info

Publication number: JP2000507952A5
Authority: JP; Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

JP1997535278A

Other languages

English (en)

Other versions

JP2000507952A (ja

Filing date

1997-03-20

Publication date

2004-12-02

1997-03-20 Application filed filed Critical

1997-03-20 Priority claimed from PCT/US1997/003986 external-priority patent/WO1997036861A1/en

2000-06-27 Publication of JP2000507952A publication Critical patent/JP2000507952A/ja

2004-12-02 Publication of JP2000507952A5 publication Critical patent/JP2000507952A5/ja

Status Abandoned legal-status Critical Current

Description

JP9535278A 1996-03-29 1997-03-20 ｍｅｔａ―置換フェニレンスルホンアミド誘導体 Abandoned JP2000507952A (ja)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US1441596P	1996-03-29	1996-03-29
US60/014,415		1996-03-29
PCT/US1997/003986 WO1997036861A1 (en)	1996-03-29	1997-03-20	Meta-substituted phenylene sulphonamide derivatives

Publications (2)

Publication Number	Publication Date
JP2000507952A JP2000507952A (ja)	2000-06-27
JP2000507952A5 true JP2000507952A5 (ja)	2004-12-02

Family

ID=21765351

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP9535278A Abandoned JP2000507952A (ja)	1996-03-29	1997-03-20	ｍｅｔａ―置換フェニレンスルホンアミド誘導体

Country Status (12)

Country	Link
US (3)	US5843906A (ja)
EP (1)	EP0889876B1 (ja)
JP (1)	JP2000507952A (ja)
AT (1)	ATE203515T1 (ja)
AU (1)	AU2420897A (ja)
CA (1)	CA2250586C (ja)
DE (1)	DE69705829T2 (ja)
DK (1)	DK0889876T3 (ja)
ES (1)	ES2160949T3 (ja)
GR (1)	GR3036887T3 (ja)
PT (1)	PT889876E (ja)
WO (1)	WO1997036861A1 (ja)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2420897A (en) *	1996-03-29	1997-10-22	G.D. Searle & Co.	Meta-substituted phenylene sulphonamide derivatives
GB9805655D0 (en)	1998-03-16	1998-05-13	Celltech Therapeutics Ltd	Chemical compounds
US6521626B1 (en)	1998-03-24	2003-02-18	Celltech R&D Limited	Thiocarboxamide derivatives
CN1140511C (zh)	1998-04-09	2004-03-03	明治制果株式会社	作为整合素αvβ3拮抗剂的氨基哌啶衍生物
GB9814414D0 (en)	1998-07-03	1998-09-02	Celltech Therapeutics Ltd	Chemical compounds
WO2000006169A1 (en) *	1998-07-29	2000-02-10	Merck & Co., Inc.	Integrin receptor antagonists
GB9821061D0 (en)	1998-09-28	1998-11-18	Celltech Therapeutics Ltd	Chemical compounds
GB9826174D0 (en)	1998-11-30	1999-01-20	Celltech Therapeutics Ltd	Chemical compounds
PL349216A1 (en)	1998-12-23	2002-07-01	Searle & Co	Method of using a cyclooxygenase-2 inhibitor and a matrix metalloproteinase inhibitor as a combination therapy in the treatment of neoplasia
US6291503B1 (en)	1999-01-15	2001-09-18	Bayer Aktiengesellschaft	β-phenylalanine derivatives as integrin antagonists
US6518283B1 (en)	1999-05-28	2003-02-11	Celltech R&D Limited	Squaric acid derivatives
AU6316900A (en)	1999-08-05	2001-03-05	Meiji Seika Kaisha Ltd.	Omega-amino-alpha-hydroxycarboxylic acid derivatives having integrin alphavbeta3antagonism
JP2003508512A (ja) *	1999-09-08	2003-03-04	ギルフォードファーマシュウティカルズインコーポレイテッド	非ペプチド性サイクロフィリン結合化合物とその用途
EP1088821A1 (en) *	1999-09-28	2001-04-04	Applied Research Systems ARS Holding N.V.	Pharmaceutically active sulfonamide derivatives
US6534513B1 (en)	1999-09-29	2003-03-18	Celltech R&D Limited	Phenylalkanoic acid derivatives
AU781747B2 (en) *	1999-10-08	2005-06-09	Meiji Seika Kaisha Ltd.	3-aminopiperidine derivatives as integrin alphavbeta3 antagonists
US20050059669A1 (en) *	1999-10-08	2005-03-17	Keiichi Ajito	M-substituted benzoic acid derivatives having integrin alpha v beta 3 antagonistic activity
US6849639B2 (en)	1999-12-14	2005-02-01	Amgen Inc.	Integrin inhibitors and their methods of use
US6455539B2 (en)	1999-12-23	2002-09-24	Celltech R&D Limited	Squaric acid derivates
AU781506B2 (en) *	2000-02-03	2005-05-26	Eisai R&D Management Co., Ltd.	Integrin expression inhibitors
ATE375330T1 (de)	2000-04-17	2007-10-15	Ucb Pharma Sa	Enamin-derivate als zell-adhäsionsmoleküle
US6403608B1 (en)	2000-05-30	2002-06-11	Celltech R&D, Ltd.	3-Substituted isoquinolin-1-yl derivatives
US6545013B2 (en)	2000-05-30	2003-04-08	Celltech R&D Limited	2,7-naphthyridine derivatives
WO2002004426A1 (en)	2000-07-07	2002-01-17	Celltech R & D Limited	Squaric acid derivatives containing a bicyclic heteroaromatic ring as integrin antagonists
EP1305291A1 (en)	2000-08-02	2003-05-02	Celltech R&D Limited	3-substituted isoquinolin-1-yl derivatives
WO2002059080A2 (en)	2001-01-25	2002-08-01	Guilford Pharmaceuticals Inc.	Trisubstituted carbocyclic cyclophilin binding compounds and their use
KR20030080013A (ko) *	2001-02-21	2003-10-10	에자이 가부시키가이샤	인테그린 발현 억제를 통한 혈관 신생 억제제의 효과를검정하는 방법
US6710061B2 (en) *	2001-03-09	2004-03-23	Ortho-Mcneil Pharamceutical, Inc.	Aminopyrrolidine sulfonamides as serine protease inhibitors
GB0127615D0 (en) *	2001-07-09	2002-01-09	Aventis Pharm Prod Inc	Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity
WO2003059251A2 (en)	2001-10-22	2003-07-24	The Scripps Research Institute	Antibody targeting compounds
AU2002364260A1 (en) *	2001-12-31	2003-07-30	Bayer Pharmaceuticals Corporation	Avb3 and avb5 integrin antagonists and methods of treating diseases or conditions associated with avb3 and avb5 integrins
CA2478239A1 (en) *	2002-03-04	2003-09-18	Medimmune, Inc.	The prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents
JP2005525368A (ja) *	2002-03-04	2005-08-25	メディミューン，インコーポレーテッド	インテグリンαｖβ３アンタゴニストをＨＭＧ−ＣｏＡ還元酵素阻害剤またはビスフォスフォネートと併用投与する障害の予防または治療方法
CA2514653A1 (en) *	2003-01-30	2004-08-12	Medimmune, Inc.	Uses of integrin alphavbeta3 antagonists
UA87854C2 (en)	2004-06-07	2009-08-25	Мерк Энд Ко., Инк.	N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
EP1917244A2 (de)	2005-08-24	2008-05-07	Abbott GmbH & Co. KG	Hetaryl substituierte guanidinverbindungen und ihre verwendung als bindungspartner für 5-ht5-rezeptoren
CA2630415A1 (en) *	2005-10-20	2007-04-26	The Scripps Research Institute	Fc labeling for immunostaining and immunotargeting
PT2222636E (pt)	2007-12-21	2013-07-16	Ligand Pharm Inc	Moduladores seletivos de recetores de andrógeno (sarms) e suas utilizações
US8518927B2 (en)	2009-02-10	2013-08-27	The Scripps Research Institute	Chemically programmed vaccination
EP3148587B1 (en)	2014-05-30	2021-02-24	Pfizer Inc	Carbonitrile derivatives as selective androgen receptor modulators
WO2023275715A1 (en)	2021-06-30	2023-01-05	Pfizer Inc.	Metabolites of selective androgen receptor modulators

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2456731A1 (fr) *	1979-05-16	1980-12-12	Choay Sa	Nouveaux derives substitues d'ary
ES2039356T3 (es) *	1985-11-12	1993-10-01	Ono Pharmaceutical Co., Ltd.	Un procedimiento para la preparacion de derivados del acido p-guanidinobenzoico.
NZ239846A (en) *	1990-09-27	1994-11-25	Merck & Co Inc	Sulphonamide derivatives and pharmaceutical compositions thereof
IL99537A (en) *	1990-09-27	1995-11-27	Merck & Co Inc	Fibrinogen receptor antagonists and pharmaceutical preparations containing them
WO1992008464A1 (en) *	1990-11-15	1992-05-29	Tanabe Seiyaku Co. Ltd.	Substituted urea and related cell adhesion modulation compounds
US5451677A (en) *	1993-02-09	1995-09-19	Merck & Co., Inc.	Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity
CA2190870A1 (en) *	1994-05-27	1995-12-07	George D. Hartman	Compounds for inhibiting osteoclast-mediated bone resorption
ES2162676T3 (es) *	1996-03-29	2002-01-01	Searle & Co	Derivados de fenileno sustituidos en meta y su uso como antagonistas o inhibidores de integrina alfav,beta3.
AU2420897A (en) *	1996-03-29	1997-10-22	G.D. Searle & Co.	Meta-substituted phenylene sulphonamide derivatives

1997
- 1997-03-20 AU AU24208/97A patent/AU2420897A/en not_active Abandoned
- 1997-03-20 ES ES97919877T patent/ES2160949T3/es not_active Expired - Lifetime
- 1997-03-20 JP JP9535278A patent/JP2000507952A/ja not_active Abandoned
- 1997-03-20 DE DE69705829T patent/DE69705829T2/de not_active Expired - Fee Related
- 1997-03-20 CA CA002250586A patent/CA2250586C/en not_active Expired - Fee Related
- 1997-03-20 PT PT97919877T patent/PT889876E/pt unknown
- 1997-03-20 EP EP97919877A patent/EP0889876B1/en not_active Expired - Lifetime
- 1997-03-20 DK DK97919877T patent/DK0889876T3/da active
- 1997-03-20 WO PCT/US1997/003986 patent/WO1997036861A1/en active IP Right Grant
- 1997-03-20 AT AT97919877T patent/ATE203515T1/de not_active IP Right Cessation
- 1997-03-27 US US08/824,626 patent/US5843906A/en not_active Expired - Fee Related
1998
- 1998-08-28 US US09/141,547 patent/US6677308B1/en not_active Expired - Fee Related
2001
- 2001-10-16 GR GR20010401757T patent/GR3036887T3/el not_active IP Right Cessation
2003
- 2003-09-08 US US10/657,570 patent/US20050176821A1/en not_active Abandoned

Publication	Publication Date	Title
JP2000502280A5 (ja)	2005-06-16
JP2000515551A5 (ja)	2005-03-10
JP2000501771A5 (ja)	2004-08-19
JP2000508096A5 (ja)	2004-11-25
JP2000501599A5 (ja)	2005-05-12
JP2000500076A5 (ja)	2005-07-14
JP2000502472A5 (ja)	2005-06-16
JP2000501825A5 (ja)	2005-04-07
JP2001503623A5 (ja)	2005-07-14
JP2000502485A5 (ja)	2005-04-07
JP2001505070A5 (ja)	2004-11-18
JP2000501774A5 (ja)	2005-04-07
JP2000502425A5 (ja)	2005-02-10
JP2000502570A5 (ja)	2004-11-18
JP2000507952A5 (ja)	2004-12-02
JP2000502568A5 (ja)	2004-11-11
JP2000501876A5 (ja)	2005-04-07
JP2000501744A5 (ja)	2004-11-11
JP2000502316A5 (ja)	2005-04-07
JP2001506750A5 (ja)	2004-10-28
JP2000502714A5 (ja)	2004-11-11
JP2000509422A5 (ja)	2004-12-09
JP2000510736A5 (ja)	2005-01-13
JP2000500318A5 (ja)	2005-04-07
JP2000501569A5 (ja)	2005-05-12